<i>SEC16A</i> Variants Predispose to Chronic Pancreatitis by Impairing ER‐to‐Golgi Transport and Inducing ER Stress
Chronic pancreatitis (CP) is a complex disease with genetic and environmental factors at play. Through trio exome sequencing, a de novo SEC16A frameshift variant in a Chinese teenage CP patient is identified. Subsequent targeted next-generation sequencing of the SEC16A gene in 1,061 Chinese CP patients and 1,196 controls reveals a higher allele frequency of rare nonsynonymous SEC16A variants in patients (4.90% vs 2.93%; odds ratio [OR], 1.71; 95% confidence interval [CI], 1.26-2.33). Similar enrichments are noted in a French cohort (OR, 2.74; 95% CI, 1.67-4.50) and in a biobank meta-analysis (OR, 1.16; 95% CI, 1.04-1.31). Notably, Chinese CP patients with SEC16A variants exhibit a median onset age 5 years earlier than those without (40.0 vs 45.0; p = 0.012). Functional studies using three CRISPR/Cas9-edited HEK293T cell lines show that loss-of-function SEC16A variants disrupt coat protein complex II (COPII) formation, impede secretory protein vesicles trafficking, and induce endoplasmic reticulum (ER) stress due to protein overload. Sec16a<sup>+/-</sup> mice, which demonstrate impaired zymogen secretion and exacerbated ER stress compared to Sec16a<sup>+/+</sup>, are further generated. In cerulein-stimulated pancreatitis models, Sec16a<sup>+/-</sup> mice display heightened pancreatic inflammation and fibrosis compared to wild-type mice. These findings implicate a novel pathogenic mechanism predisposing to CP.
Authors
- Vinciane Rebours (ORCID: https://orcid.org/0000-0002-0000-4525)
- Xin‐Ying Tang (ORCID: https://orcid.org/0009-0006-3815-8008)
- Shun‐Jiang Deng (ORCID: https://orcid.org/0000-0002-4663-2287)
- Liang‐Hao Hu (ORCID: https://orcid.org/0000-0001-7535-7475)
- Zhuan Liao (ORCID: https://orcid.org/0000-0001-8506-8159)
- D.N. Cooper (ORCID: https://orcid.org/0000-0002-8943-8484)
- Claude Férec (ORCID: https://orcid.org/0000-0002-2325-0710)
- Yuan‐Chen Wang (ORCID: https://orcid.org/0000-0002-7839-2564)
- Emmanuelle Masson (ORCID: https://orcid.org/0000-0001-9777-523X)
- Yang‐Yang Qian (ORCID: https://orcid.org/0009-0006-0007-276X)
- Dong Yu (ORCID: https://orcid.org/0000-0001-6089-4905)
- Jian‐Min Chen
- Lijuan Wang (ORCID: https://orcid.org/0000-0001-5944-3453)
- Zhao‐Shen Li
- Min‐Jun Wang
- Wen‐Bin Zou
- Yahui Wang (ORCID: https://orcid.org/0009-0004-5535-4858)
- Lei Wang (ORCID: https://orcid.org/0000-0003-0734-7026)
Institutions
- Inserm (FR)
- Université de Bretagne Occidentale (FR)
- Second Military Medical University (CN)
- École nationale d'ingénieurs de Brest (FR)
- Université Paris Cité (FR)
- Hôpital Beaujon (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Changhai Hospital (CN)
- Centre Hospitalier Régional Universitaire de Brest (FR)
- Eastern Hepatobiliary Surgery Hospital (CN)
- Génétique, Génomique Fonctionnelle et Biotechnologies (FR)
- Cardiff University (GB)
Publication Details
- Journal
- Advanced Science
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1002/advs.202402550
- Citations
- 9
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.15
Funders
- Institut National de la Santé et de la Recherche Médicale
- National Natural Science Foundation of China